Glenmark Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

02 Dec 2020 | 03:59 PM

479.50
2.80 (0.59%)

  • Underperforms Index

    46.66%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 5.78%

  • More Volatile

    3.72%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.02%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

573

572.70

168

168.00

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Glenmark Pharmaceuticals Ltd has increased by 10.21% since past 3 Months

  • MF shareholding in Glenmark Pharmaceuticals Ltd has increased by 51.36% since past 3 Months

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -17.79% since past 1 Year

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -17.37% since past 1 Year

Loading...